Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
8.48%
↑ 101% vs avg
Percentile
P100
Near historical high
Streak
9 yr
Consecutive growthExpanding
Average
-586.05%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.48% | +52.5% |
| 2024 | 5.56% | +124.1% |
| 2023 | -23.06% | +62.0% |
| 2022 | -60.62% | +8.7% |
| 2021 | -66.40% | +28.7% |
| 2020 | -93.14% | +48.9% |
| 2019 | -182.32% | +48.4% |
| 2018 | -353.41% | +69.5% |
| 2017 | -1159.73% | +70.5% |
| 2016 | -3935.88% | - |